José Alcamí

Grupo de investigación

Sida e infección por VIH Accredited researcher (R3A)

alcami@clinic.cat 0000-0003-0023-7377

Síguelo/a en:

El perfil de twitter de José . Este enlace se abre en una nueva pestaña.

Publicaciones destacadas

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Autores:
Borobia, Alberto M; Carcas, Antonio J; Perez-Olmeda, Mayte; Castano, Luis; Jesus Bertran, Maria;

(...)

Ramon Arribas, Jose; Ochando, Jordi; Alcami, Jose; Belda-Iniesta, Cristobal; Frias, Jesus.

Referencia: Lancet 2021.
Recommendations for measuring HIV reservoir size in cure-directed clinical trials

Autores:
Abdel-Mohsen, Mohamed; Richman, Douglas; Siliciano, Robert F; Nussenzweig, Michel C; Howell, Bonnie J;

(...)

Fox, Lawrence; Frank, Ian; Riley, James L; Tebas, Pablo; Montaner, Luis J.

Referencia: Nature Medicine 2020.
Association of a single nucleotide polymorphism in the ubxn6 gene with long-term non-progression phenotype in HIV-positive individuals

Autores:
Diez-Fuertes, F; De La Torre-Tarazona, H E; Calonge, E; Pernas, M; Bermejo, M;

(...)

Lopez-Galindez, C; Lathrop, M; Dopazo, J; Sakuntabhai, A; Alcami, J.

Referencia: Clinical Microbiology And Infection 2020.
The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection

Autores:
Rodriguez-Mora, Sara; De Witid, Flore; Garcia-Perez, Javier; Bermejo, Mercedes; Lopez-Huertas, Maria Rosa;

(...)

Christ, Frauke; Debyser, Zeger; Vilchez, Juan Jesus; Coiras, Mayte; Alcami, Jose.

Referencia: Plos Pathogens 2019.
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence

Autores:
Sliepen, Kwinten; Han, Byung Woo; Bontjer, Ilja; Mooij, Petra; Garces, Fernando;

(...)

Moore, John P; Shattock, Robin J; Bogers, Willy M; Wilson, Ian A; Sanders, Rogier W.

Referencia: Nature Communications 2019.
IL-7 Induces SAMHD1 Phosphorylation in CD4+T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle

Autores:
Coiras, Mayte; Bermejo, Mercedes; Descours, Benjamin; Mateos, Elena; Garcia-Perez, Javier;

Lopez-Huertas, Maria-Rosa; Lederman, Michael M; Benkirane, Monsef; Alcami, Jose.

Referencia: Cell Reports 2016.
Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon

Autores:
Lopez-Huertas, M R; Callejas, S; Abia, D; Mateos, E; Dopazo, A;

Alcami, J; Coiras, M.

Referencia: Nucleic Acids Research 2010.
SDF-1/CXCL12 Production by Mature Dendritic Cells Inhibits the Propagation of X4-Tropic HIV-1 Isolates at the Dendritic Cell-T-Cell Infectious Synapse

Autores:
Gonzalez, Nuria; Bermejo, Mercedes; Calonge, Esther; Jolly, Clare; Arenzana-Seisdedos, Fernando;

Pablos, Jose L; Sattentau, Quentin J; Alcami, Jose.

Referencia: Journal Of Virology 2010.
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs

Autores:
Coiras, Mayte; Rosa Lopez-Huertas, Maria; Perez-Olmeda, Mayte; Alcami, Jose;

Referencia: Nature Reviews Microbiology 2009.
ABSOLUTE DEPENDENCE ON KAPPA-B RESPONSIVE ELEMENTS FOR INITIATION AND TAT-MEDIATED AMPLIFICATION OF HIV TRANSCRIPTION IN BLOOD CD4 T-LYMPHOCYTES

Autores:
ALCAMI, J; DELERA, TL; FOLGUEIRA, L; PEDRAZA, MA; JACQUE, JM;

(...)

HAY, RT; HARRICH, D; GAYNOR, RB; VIRELIZIER, JL; ARENZANASEISDEDOS, F.

Referencia: Embo Journal 1995.

Proyectos destacados

Generation of HIV immunogens based on the envelope of Founder viruses from patients with broad neutralizing responses

Investigador/a principal: José Alcamí Pertejo, Nuria Gonzalez

Financiador: Instituto de Salud Carlos III (ISCIII)

Código: MPY 388/23

Duración: 01/01/2024 - 01/01/2026
Phase I Clinical trial to evaluate safety and immunogenicity of a preventive HIV vaccine based on the envelope from founder viruses (HIVACFOUND)

Financiador: Instituto de Salud Carlos III (ISCIII)

Código: ICI23/00025

Duración: 01/01/2024 - 01/01/2026
Characterization of a mutation in the Transportin 3 gene that protects from HIV infection

Investigador/a principal: José Alcamí Pertejo, Javier García Pérez

Financiador: Ministerio de Ciencia, Innovación y Universidades

Código: PID2021-125978OB-C21

Duración: 01/01/2023 - 01/01/2025
EAVI 2020: EUROPEAN AIDS VACCINE INITIATIVE 2020

Investigador/a principal: R Shattock, José Alcamí Pertejo

Financiador: Unión Europea

Código: UE H2020: 681137

Duración: 01/01/2016 - 01/01/2023
Spanish AIDS Research Network

Investigador/a principal: José Alcamí Pertejo

Financiador: Ministerio de Ciencia, Innovación y Universidades

Código: RD16CIII/0002/01

Duración: 01/01/2016 - 01/01/2022

José Alcamí

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

Generation of HIV immunogens based on the envelope of Founder viruses from patients with broad neutralizing responses

Phase I Clinical trial to evaluate safety and immunogenicity of a preventive HIV vaccine based on the envelope from founder viruses (HIVACFOUND)

Characterization of a mutation in the Transportin 3 gene that protects from HIV infection

EAVI 2020: EUROPEAN AIDS VACCINE INITIATIVE 2020

Spanish AIDS Research Network

Suscríbete a la Newsletter del Clínic